Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPARES: Fresh Frozen Plasma in Sepsis
NCT07160426Phase 2Not yet recruiting
- Sponsor
- Beth Israel Deaconess Medical Center
- Start
- Jul 2026
- Primary completion
- Jun 2028
- Modality
- Recombinant Proteins and Enzymes, Tissue Cells
01
Overview
A Phase 2 trial of fresh-frozen plasma in sepsis, sponsored by Beth Israel Deaconess Medical Center. Planned start Jul 2026; status: not yet recruiting.
02
Drugs
fresh-frozen plasma
03
Conditions
sepsis
Beyond the preview
Go deeper on NCT07160426.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07160426.